VBCVX
Price
$15.49
Change
+$0.10 (+0.65%)
Updated
Jul 3 closing price
Net Assets
474.8M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

VBCVX vs VIVAX

Header iconVBCVX vs VIVAX Comparison
Open Charts VBCVX vs VIVAXBanner chart's image
VALIC Company I Systematic Value
Price$15.49
Change+$0.10 (+0.65%)
VolumeN/A
Net Assets474.8M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
VBCVX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VBCVX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VBCVX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. VBCVX (475M). VIVAX pays higher dividends than VBCVX: VIVAX (2.06) vs VBCVX (1.65). VBCVX was incepted earlier than VIVAX: VBCVX (20 years) vs VIVAX (33 years). VBCVX (0.79) is less costly to investors than VIVAX (0.17). VBCVX is a more actively managed with annual turnover of: 75.00 vs. VIVAX (9.00). VBCVX has a lower initial minimum investment than VIVAX: VBCVX (0) vs VIVAX (3000). VBCVX annual gain was more profitable for investors over the last year : 13.85 vs. VIVAX (12.04). VIVAX return over 5 years is better than : 80.14 vs. VBCVX (44.45).
VBCVXVIVAXVBCVX / VIVAX
Total Expense Ratio0.650.17382%
Annual Report Gross Expense Ratio0.790.17465%
Fund Existence20 years33 years-
Gain YTD4.6926.20976%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets475M189B0%
Annual Yield % from dividends1.652.0680%
Returns for 1 year13.8512.04115%
Returns for 3 years34.7635.1699%
Returns for 5 years44.4580.1455%
Returns for 10 years16.18115.7414%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.